Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity

Emily E. Marshall, Daniel Malouli, Scott G. Hansen, Roxanne M. Gilbride, Colette M. Hughes, Abigail B. Ventura, Emily Ainslie, Andrea N. Selseth, Julia C. Ford, David Burke,

Science Translational Medicine · 2019 · 34 citations · 60 references

Concepts

Abstract

phenotype, epitope targeting, and durability. Thus, pp71 deletion preserves CMV vector immunogenicity while stringently limiting vector spread, making pp71 deletion an attractive attenuation strategy for HCMV vectors.

References

60